The Food and Drug Administration says data from recent clinical studies show the benefits of the drug Avastin for *** cancer patients don't outweigh the risks. Roche's Genentech unit disagrees and wants to keep marketing the drug for that use
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/12/16/132111591/fda-to-pull-approval-of-avastin-for-breast-cancer?ft=1&f=103537970
Posted
Dec 16 2010, 12:30 PM
by
NPR Blogs: Shots - Health News Blog